Misplaced Pages

International Federation of Pharmaceutical Manufacturers & Associations

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
(Redirected from International Federation of Pharmaceutical Manufacturers Associations)
This article relies excessively on references to primary sources. Please improve this article by adding secondary or tertiary sources.
Find sources: "International Federation of Pharmaceutical Manufacturers & Associations" – news · newspapers · books · scholar · JSTOR (October 2023) (Learn how and when to remove this message)
International Federation of Pharmaceutical Manufacturers & Associations
AbbreviationIFPMA
Formation1968
TypeTrade association
HeadquartersGeneva, Switzerland
PresidentAlbert Bourla
Key peopleAlbert Bourla (chairman, president and CEO)
Dr Thomas Schinecker (Vice President)
Websitehttps://www.ifpma.org/

The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is a trade association that represents internationally over 90 pharmaceutical companies and associations around the world. IFPMA is based in Geneva and is in official relations with the United Nations where it contributes industry expertise to global health discussions.

It was formed in 1968 and is based in Geneva, Switzerland.

In 2019, IFPMA released a strengthened code of ethics and professional standards. Among the revisions to the code is a prohibition on gifts provided to healthcare professionals. The code revision has been followed by Ethoscope – an open-source, continuously evolving resource that contains diverse guidance designed to keep pace with emerging developments.

The pharmaceutical industry contributes to the Sustainable Development Goals (SDGs), in particular Goal 3 to ensure healthy lives and promote well-being for all at all ages. Today over 35 IFPMA member companies contribute resources and knowhow to SDG initiatives partnering with academia, development organizations, NGOs, foundations and other business sectors. There are over 250 collaborations that aim to strengthen health systems and expand quality healthcare access.

IFPMA works in partnership with other members of the global health community to achieve Universal Health Coverage (UHC) targets and contribute to a world where no one is left behind in receiving the healthcare they need. A wide range of stakeholders across the public and private sectors have an opportunity to collaborate more closely to increase affordability of and access to essential medicines, and the low-cost, but highly effective, interventions and screenings.

Leadership

Since 2022, Dr Albert Bourla, chairman and CEO of Pfizer has served as President and Dr Thomas Schinecker, CEO of Roche serves as Vice-President.

In November 2024, IFPMA announced that Thomas Schinecker would replace Albert Bourla as President. Robert M. Davis, CEO of Merck & Co., and Dr Sunao Manabe, CEO of Daiichi Sankyo, will serve as Vice-Presidents.

See also

References

  1. CEOs from Pfizer, Roche, and Daiichi Sankyo take up roles on IFPMA CEO leadership team,IFPMA,12 July 2023,
  2. "International Federation of Pharmaceutical Manufacturers & Associations - IFPMA". Retrieved 2 November 2023.
  3. "List of NGOs accredited at the UN Office at Geneva". Retrieved 7 December 2022.
  4. "About IFPMA". Archived from the original on 26 June 2014. Retrieved 11 Jun 2014.
  5. "New International Pharmaceutical Practice Code Tightens Restrictions on Gifts". Ropes & Gray. 27 February 2019. Retrieved 30 October 2023.
  6. Underwood, George (18 Mar 2020). "Industry and patient groups collaborate on new guidance for interaction". Retrieved 7 December 2022.
  7. Baker, Berry (20 December 2018). "IFPMA launches new Code of Practice for the pharmaceutical industry". Pharma Technology. Retrieved 30 October 2023.
  8. Lugogo, Mwana (24 April 2023). "Industry and patient groups collaborate on new guidance for interaction". PharmaBoardroom. Retrieved 30 October 2023.
  9. "Goal 3: Ensure healthy lives and promote well-being for all at all ages". United Nations. Retrieved 30 October 2023.
  10. Explore Collaborations Global Health Progress 2023,https://globalhealthprogress.org/explore-our-collaborations/
  11. "Global Health Progress is an interactive resource hub highlighting collaborations between the innovative biopharmaceutical industry and our partners to support the SDGs". 18 Mar 2022. Retrieved 7 December 2022.
  12. "Private Sector Commitments To Universal Health Coverage, UHC2030 Private Sector Constituency 2023 Statement" (PDF). UHC2030. Retrieved 30 October 2023.
  13. "The Road to 2030: Revitalizing Multi-sectoral Partnerships to Achieve Universal Health Coverage". Foreign Policy Analytics. Retrieved 30 October 2023.
  14. "Roche CEO named as new president of IFPMA". www.thepharmaletter.com. Retrieved 2024-11-27.
  15. EFPIA, https://www.ifpma.org/members/efpia/
  16. Interpharma, https://www.ifpma.org/members/interpharma/
  17. IPASA, https://www.ifpma.org/members/ipasa/
  18. JPMA, https://www.ifpma.org/members/jpma/
  19. LEEM, https://www.ifpma.org/members/leem/

External links

Category: